癫痫患者骨密度改变的性别差异及相关影响因素分析(4)
| 第1页 |
参见附件。
[9] Phabphal K，Geater A，Limapichart K，et al. The association between BsmI polymorphism and bone mineral density in young patients with epilepsy who are taking phenytoin[J].Epilepsia，2013，54(2)： 249-255.
[10] Beerhorst K，Van der Kruijs SJ，Verschuure P，et al. Bone disease during chronic antiepileptic drug therapy：general versus specific risk factors[J]. J Neurol Sci，2013，331(1-2)：19-25.
[11] Pack AM， Morrell MJ， Randall A， et al. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy[J]. Neurology， 2008，70(18)：1586-1593.
[12] Harden CL. Menopause and bone density issues for women with epilepsy[J]. Neurology，2003，61(suppl 2)：S16-S22.
[13] Shiek Ahmad B， Hill KD， O'Brien TJ， et al. Falls and fractures in patients chronically treated with antiepileptic drugs[J]. Neurology， 2012，79(2)：145-151.
[14] Jette N，Lix LM，Metge CJ，et al. Association of antiepileptic drugs with nontraumatic fractures：A population-based analysis[J]. Arch Neurol，2011，68(1)：107-112.
[15] Sheth RD，Harden CL. Screening for bone health in epilepsy[J]. Epilepsia，2007，48(Suppl 9)：s39-41.
[16] Pack AM. The association between antiepileptic drugs and bone disease[J]. Epilepsy Curr，2003，3(3)： 91-95.
[17] Sheth RD，Binkley N，Hermann BP. Gender differences in bone mineral density in epilepsy[J]. Epilepsia，2008，49(1)：125-131.
[18] Nicholas JM，Ridsdale L，Richardson MP，et al. Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy：Cohort study using the general practice research database[J]. Seizure，2013，22(1)：37-42.
(收稿日期：2014-09-25)
您现在查看是摘要介绍页，详见PDF附件。